Antibody Drug Conjugates Design, Discovery, and Development
Category: eBooks
- views: 91
- date: 8 January 2026
- posted by: BeMyLove
Antibody Drug Conjugates Design, Discovery, and Development | 8.47 MB
Title: Antibody Drug Conjugates
Author: Hobson, Adrian
Category: Nonfiction, Science & Nature, Science, Chemistry, Organic, Health & Well Being, Medical, Specialties, Pharmacy, Medical Science, Pharmacology
Language: English | 235 Pages | ISBN: 3031287312
Description:
This volume provides a comprehensive recapitulation of structure-activity relationship (SAR) from a mechanism of action point of view for this unique therapeutic modality, in a largely disease agnostic manner. From a disease biology and pharmacology perspective, the cellular target and drug-conjugate selection, considerations on liker -chemistry and -antibody ratio, and formulation science and technology, to get from bench to bedside (i.e. from a laboratory to the systemic circulation in a patient). The book also provides an understanding around target binding and drug/"payload" release mechanisms. Furthermore, pharmacokinetic and safety pharmacological aspects from a regulatory and clinical perspective are discussed, along with current chemistry, manufacturing, controls guidance and emerging novel delivery devices or technologies.
The key differentiation in Antibody Drug Conjugates is the clinical and development discussion, that offers pragmatic considerations in medical product development, IP, regulatory considerations, among others. Furthermore, we discuss the topic as a platform, in a disease agnostic manner.
DOWNLOAD:
https://rapidgator.net/file/a87d5170322545cf6985340fc940063b/Antibody_Drug_Conjugates_Design_Discovery_and_Development.pdf
https://nitroflare.com/view/C6C73EB6CDD14D8/Antibody_Drug_Conjugates_Design_Discovery_and_Development.pdf
This volume provides a comprehensive recapitulation of structure-activity relationship (SAR) from a mechanism of action point of view for this unique therapeutic modality, in a largely disease agnostic manner. From a disease biology and pharmacology perspective, the cellular target and drug-conjugate selection, considerations on liker -chemistry and -antibody ratio, and formulation science and technology, to get from bench to bedside (i.e. from a laboratory to the systemic circulation in a patient). The book also provides an understanding around target binding and drug/"payload" release mechanisms. Furthermore, pharmacokinetic and safety pharmacological aspects from a regulatory and clinical perspective are discussed, along with current chemistry, manufacturing, controls guidance and emerging novel delivery devices or technologies.
The key differentiation in Antibody Drug Conjugates is the clinical and development discussion, that offers pragmatic considerations in medical product development, IP, regulatory considerations, among others. Furthermore, we discuss the topic as a platform, in a disease agnostic manner.
DOWNLOAD:
https://rapidgator.net/file/a87d5170322545cf6985340fc940063b/Antibody_Drug_Conjugates_Design_Discovery_and_Development.pdf
https://nitroflare.com/view/C6C73EB6CDD14D8/Antibody_Drug_Conjugates_Design_Discovery_and_Development.pdf
We need your support!
Make a donation to help us stay online
Bitcoin (BTC)
bc1q08g9d22cxkawsjlf8etuek2pc9n2a3hs4cdrld
Bitcoin Cash (BCH)
qqvwexzhvgauxq2apgc4j0ewvcak6hh6lsnzmvtkem
Ethereum (ETH)
0xb55513D2c91A6e3c497621644ec99e206CDaf239
Litecoin (LTC)
ltc1qt6g2trfv9tjs4qj68sqc4uf0ukvc9jpnsyt59u
USDT (ERC20)
0xb55513D2c91A6e3c497621644ec99e206CDaf239
USDT (TRC20)
TYdPNrz7v1P9riWBWZ317oBgJueheGjATm
Information |
|||
 |
Users of GUESTS are not allowed to comment this publication. | ||